Inventor
HUNTINGTON JAMES ANDREW
GB15 patents
⚠️ This page may combine multiple inventors who share the name “HUNTINGTON JAMES ANDREW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICALS INC
8 patentsUS9605082B2Mar 28, 2017
Thrombin-binding antibody molecules and uses thereof
JANSSEN PHARMACEUTICALS INC11 citations91
US9518129B2Dec 13, 2016
Thrombin-binding antibody molecules and uses thereof
JANSSEN PHARMACEUTICALS INC9 citations82
US9518128B2Dec 13, 2016
Thrombin-binding antibody molecules
JANSSEN PHARMACEUTICALS INC10 citations82
US10370454B2Aug 6, 2019
Thrombin-binding antibody molecules and uses thereof
JANSSEN PHARMACEUTICALS INC1 citations71
US9988461B2Jun 5, 2018
Thrombin-binding antibody molecules and uses thereof
JANSSEN PHARMACEUTICALS INC3 citations71
US9988463B2Jun 5, 2018
Thrombin-binding antibody molecules and uses thereof
JANSSEN PHARMACEUTICALS INC3 citations71
US11155637B2Oct 26, 2021
Thrombin-binding antibody molecules and uses thereof
JANSSEN PHARMACEUTICALS INC0 citations61
US10287363B2May 14, 2019
Thrombin-binding antibody molecules and uses thereof
JANSSEN PHARMACEUTICALS INC0 citations50
CENTESSA PHARMACEUTICALS UK LTD
4 patentsUS12221422B2Feb 11, 2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency
CENTESSA PHARMACEUTICALS UK LTD0 citations60
US12365672B2Jul 22, 2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency
CENTESSA PHARMACEUTICALS UK LTD0 citations57
US12291507B2May 6, 2025
Compounds and their use for the treatment of ALPHA1-antitrypsin deficiency
CENTESSA PHARMACEUTICALS UK LTD0 citations57
US12286402B2Apr 29, 2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency
CENTESSA PHARMACEUTICALS UK LTD0 citations57